ҵ

DICOM - Interventional X-ray
Support documentation

Support documentation

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Interventional X-ray Connectivity

DICOM Conformance Statements
 

Allura Xper Flat Detector

  • (June 2013)
  • (February 2013)
  • (May 2012)
  • (February 2011)
  • (June 2009)
  • (October 2007)
  • (January 2009)
  • (October 2007)
  • (May 2006)
  • (November 2005)
  • (June 2009)
  • (October 2007)
  • (May 2006)
  • (November 2005)
  • (January 2006)
  • (June 2009)
  • (November 2006)
  • (July 2005)
  • (June 2009)
  • (November 2006)
  • (July 2005)
  • (November 2003)

 

Allura Centron

  • (November 2012)

 

Allura FC

  • (August 2012)


Allura CV

  • (October 2008)

 

Integris Allura Systems

  • (June 2004) with High-speed DICOM Interface (MCV2974), Cardiac XA (MCV3621), Vascular XA (MCV3761), RIS (MCV3031) and Print (MCV7011).


Integris V Systems

  • (July 1996)
  • (September 1998)
  • (July 1999)
  • (June 2003)


Integris H Systems

  • (July 1996)
  • (September 1998)
  • (July 1999)
  • (June 2003)

 

DCI Systems

  • (October 1999)
     

 

EP Navigator Systems
The conformance statements of these systems can be found .

Interventional Patient Care

  • (May 2008)
  • (August 2004)
  • (October 2003)
  • (August 2004)
  • (October 2003)
     

Mobile Surgery Systems

  • (November 2014)

  • (August 2014)
  • (September 2013)
  • (September 2012)
  • (September 2013)
  • (March 2012)
  • (October 2010)
  • (with ViewForum R6.3) (August 2009)

 

  • (BV Endura R2.3 and BV Pulsera R2.3) (September 2013)
  • (BV Endura R2.3 and BV Pulsera R2.3) (March 2012)
  • (October 2010)
  • (with ViewForum R6.3) (May 2008)
  • (with ViewForum R6.3) (June 2008)
  • (with ViewForum R6.1) (March 2008)
  • (with ViewForum R4.2) (December 2006)
  • (September 2006)
  • (with ViewForum R6.3) (June 2008)
  • (with ViewForum R6.1) (May 2007)
  • (July 2005)
  • (May 2004)
  • (February 2004)
  • (July 2003)
  • (July 2002)
  • (June 2000)
  • (April 2001)

 

Conformance Statements Cardio-Vascular specific workstations

(for general workstations see the workstation section)

 

Interventional Workspot

  •  (February 2015)

 

Interventional Workspot Application Annexes

  • (March 2015)
  • (March 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)
  • (February 2015)

 

Allura Xper Systems

  • (December 2013) This Conformance Statement is applicable for the following products: Interventional Work Spot 1.2.0, Allura 3DRA 6.4.0, Allura 3DCA 3.0.5, XperGuide 1.1.0, XperCT 3.2.0, StentBoost 4.2.0, CT TrueView 2.0.5, HeartNavigator 2.0.0, 2D Perfusion 1.1.0, 3D Roadmap 1.1.1, MR-CT Roadmap 1.1.1, Embo Guide 1.0.0
  • (February 2013) This Conformance Statement is applicable for the following products: Interventional Workspot R1.1.0, HeartNavigator R1.1.1, Allura 3D-RA R6.3.0, 3D Roadmap R1.1.0, MR-CT Roadmap R1.1.0, XperCT R3.1.0, XperGuide R1.0.1, StentBoost R4.1.0, 2D Perfusion R1.0.1, Allura 3D-CA R3.0.4, CT TrueView R2.0.4
  • (April 2012) This Conformance Statement is applicable for the following products: Interventional Workspot R1.1, Allura 3D-RA R6.2, Allura 3D-CA R3.0, XperGuide R1.0, XperCT R3.0, StentBoost R4.0, CT TrueView R2.0, HeartNavigator R1.1, 2D Perfusion R1.0, 3D Roadmap R1.0, MR-CT Roadmap R1.0.
  • (March 2011) This Conformance Statement is applicable for the following products: Allura 3D-RA R6.1.0, Allura XperCT R2.2.0, StentBoost R2.1.1 and R3.1.1, Allura 3D-CA R3.0.1, CTTrueView R2.0.1, and HeartNavigator R1.0.0.
  • (March 2010) This Conformance Statement is applicable for the following products: Allura 3D-RA R6, 3D Roadmap R2, MultiModality Roadmap R1, Allura XperCT R2, Allura XperGuide R2, StentBoost R2 and R3, Allura 3D-CA R3, CTTrueView R2, and CTO Navigator.
  • (August 2009) This Conformance Statement is applicable for the following products: Allura 3D-RA R6, 3D Roadmap R2, MultiModality Roadmap R1, Allura XperCT R2, Allura XperGuide R2, StentBoost R2 and R3, Allura 3D-CA R3, CTTrueView R2, and CTO Navigator.
  • (February 2008) This Conformance Statement is applicable for the following products: Allura 3D-RA Release 5, StentBoost Release 2 and 3, Allura 3D-CA Release 2, CTTrueView Release 1, and Allura XperCT Release 2.
  • (July 2007) This Conformance Statement is applicable for the following products: Allura 3D-RA Release 5, StentBoost Release 2 and 3, Allura 3D-CA Release 2 and CTTrueView Release 1.
  • (December 2006) This Conformance Statement is applicable for the following products: Allura 3D-RA Release 5, StentBoost Release 2, Allura 3D-CA Release 1 and XperCT Release 1.
  • (June 2005) This Conformance Statement is applicable for the following products: Integris 3DRA R4.3, Allura 3D-CA 1.0 and StentBoost 2.0.
  • (August 2004)
  • (July 2004) This Conformance Statement is applicable for the following products: Integris 3DRA R4.2, Xper FD 20 R.2.0 and StentBoost R.1.
  • (January 2004)
  • (July 2003)

 

Integris (C/V) Systems

  • (January 2004)
  • (August 2004)
  • (July 2004) This Conformance Statement is applicable for the following products: Integris 3DRA R4.2, Xper FD 20 R.2.0 and StentBoost R.1.
  • (July 2003)
  • (July 2002)
  • (June 2001)
  • (November 1999)

 

CD-Medical Recorder for DCI systems

  • (July 1998)
  • (August 1996)



CD-Medical Recorder for Integris H systems

  • (July 1998)
  • (August 1996)

 

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.